Campbell & CO Investment Adviser LLC Halozyme Therapeutics, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.14 Billion
- Q1 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 33,558 shares of HALO stock, worth $1.75 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
33,558
Previous 17,369
93.21%
Holding current value
$1.75 Million
Previous $641,000
112.95%
% of portfolio
0.12%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$949 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$679 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$337 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$214 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$197 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.24B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...